Sep 21, 2026 07:00AM
Sep 21, 2026 07:00AM
Aug 24, 2026 06:30PM
Aug 24, 2026 06:30PM
Jul 13, 2026 07:01AM
Jul 13, 2026 07:00AM
Jun 17, 2026 04:15PM Alkermes narcolepsy drug meets phase 2 trial endpoints
Jun 17, 2026 04:15PM
Jun 15, 2026 07:02AM
Jun 15, 2026 07:00AM
Jun 4, 2026 07:00AM
Jun 4, 2026 07:00AM
May 26, 2026 07:00AM
May 21, 2026 07:00AM Alkermes Showcases Data From Psychiatry Portfolio and Sleep Research into Real World Patient Experience at Spring 2026 Scientific Conferences
May 12, 2026 07:00AM
May 12, 2026 07:00AM
Apr 16, 2026 07:00AM
Apr 16, 2026 07:00AM
Apr 14, 2026 07:00AM
Apr 14, 2026 07:00AM
Apr 1, 2026 07:00AM Alkermes initiates phase 3 trials for narcolepsy drug alixorexton
Apr 1, 2026 07:00AM
Mar 24, 2026 08:52AM
Feb 25, 2026 06:55AM
Feb 25, 2026 06:55AM
Feb 12, 2026 07:30AM
Feb 12, 2026 07:30AM
Jan 6, 2026 07:04AM Alkermes receives FDA breakthrough therapy designation for narcolepsy drug
Jan 6, 2026 07:00AM
Nov 19, 2025 06:00AM
Nov 19, 2025 06:00AM
Nov 17, 2025 05:52AM
Nov 17, 2025 05:45AM
Nov 14, 2025 05:45AM
Nov 14, 2025 05:45AM Avadel Receives Unsolicited Proposal from Lundbeck
Nov 12, 2025 09:57AM
Oct 28, 2025 07:00AM
Oct 22, 2025 07:00AM
Oct 22, 2025 07:00AM
Sep 10, 2025 09:16AM
Jul 29, 2025 07:00AM
Jun 2, 2025 07:00AM Alkermes Highlights Data From Psychiatry Portfolio at Spring 2025 Scientific Conferences
May 1, 2025 07:00AM
Feb 12, 2025 07:00AM
Jan 29, 2025 09:12AM
Jan 6, 2025 10:35AM
Jan 2, 2025 01:02PM
Oct 24, 2024 07:00AM
Jul 24, 2024 07:00AM Alkermes plc Reports Second Quarter 2024 Financial Results
May 14, 2024 07:00AM

332,796 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All